Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

American College of Physicians prostate cancer guideline highlights need for improved screening methods.

This article was originally published in The Gray Sheet

Executive Summary

PROSTATE CANCER GUIDELINE HIGHLIGHTS NEED FOR IMPROVED SCREENING METHODS and recommends that physicians "individualize" screening decisions in consultation with patients, in light of the "lack of direct evidence showing a net benefit of screening" for the disease. The American College of Physicians' prostate cancer screening guideline was published in the March 15 issue of ACP's Annals of Internal Medicine.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT007770

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel